Brief: Acurx Announces Results Of Its Pioneering Research With Ibezapolstat
24/09/2024 12:03
Sept 24 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX ANNOUNCES RESULTS OF ITS PIONEERING RESEARCH WITH
IBEZAPOLSTAT IN COLLABORATION WITH LEIDEN UNIVERSITY MEDICAL
CENTER AT THE PREMIER INTERNATIONAL C. DIFFICILE SYMPOSIUM
* ACURX PHARMACEUTICALS INC - FDA AGREES ON KEY ELEMENTS FOR
PHASE
3 TRIALS OF IBEZAPOLSTAT
Source text for Eikon: ID:nPn498Lzca
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program